Stem Cells Translational Medicine

Papers
(The H4-Index of Stem Cells Translational Medicine is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Invasive therapy for children with autism is not justified146
Results of a Multicenter Evaluation of a Rapid Flow Cytometry Potency Assay for Cryopreserved Cord Blood Units: A BEST Collaborative Study121
Expanded Access Protocol of Umbilical Cord Blood Infusion for Children with Neurological Conditions: An Update105
18 Years of Cord Blood Banking in Ukraine: Current Status and Future Prospects83
Optimization of T-Cell Suppression Potency Assay for Human Cord Tissue Mesenchymal Stromal Cells76
Identification and Successful Re-Consent of Existing Cord Blood Donors for the Creation of Induced Pluripotent Stem Cell Lines51
Safety of Combined Autistic Spectrum Disorders Treatment with Umbilical Cord Mesenchymal Stem Cells Application: Clinical Investigation48
Mesenchymal Stem Cells and Three-Dimensional-Osteoconductive Scaffold Regenerate Calvarial Bone in Critical Size Defects in Swine46
44
Abstract 5 Human Umbilical Cord Blood-Derived Cell Therapy Product, DUOC-01, Promotes Remyelination by Driving the Differentiation of Oligodendrocyte Progenitor Cells41
Abstract 6 Combined Umbilical Cord Mesenchymal Stromal/Stem Cell Application For Primary Torsion Dystonia Treatment (Case Report)38
Abstract 32 Expanded Umbilical Cord Blood CD34+ Cells Are Immunomodulatory in a Rat Model of Neonatal Brain Injury37
Abstract 4 Excellent Event-Free-Survival and Immunoglobulin Independence for Patients with Severe Combined Immunodeficiency Transplanted with Umbilical Cord Blood Stem Cells34
Abstract 11 Monitoring Cord Blood Inventory Reliability by Key Quality Indicators At and After Release33
Ethical issues concerning a pay-to-participate stem cell study33
Issue Information31
A preview of selected articles30
A Preview of Selected Articles—September 202130
Abstract 20 A Rapid and Sensitive IL-3-Based Assay Reveals How Various Pre-Processing Conditions Affect the Potency of Hematopoietic Stem Cells in Fresh Cord Blood Units29
Abstract 28 Comparative Analysis of the Cord Blood Bank in Quebec28
Abstract 13 A Randomized, Placebo-Controlled, Phase II Trial of Intravenous Allogeneic Umbilical Cord Blood Infusion for Adults with Ischemic Stroke28
Abstract 25 ECTmatch: Optimizing Small-Scale Cord Blood Banking Through HLA Analysis28
Abstract 30 Should Cord Blood Unit Distribution Patterns Impact Collection Strategies?28
Abstract 16 New Advanced Therapy Medicinal Products (ATMPs) in Medical Trials: A FamiCord Group Development Pipeline Update27
Abstract 11 Outcome of Patients Treated with Umbilical Cord Blood and Homologous Serum Eye Drops27
Histone Trimethylations and HDAC5 Regulate Spheroid Subpopulation and Differentiation Signaling of Human Adipose-Derived Stem Cells25
Abstract 11: Multicomponent Cord Blood Bank Program, Beyond Transplantation25
Improving the future of clinical trials and translation of mesenchymal stromal cell therapies for neonatal disorders25
Abstract 2 Development of CAR-NK Cell Therapy for Hematologic Malignancies25
0.086022853851318